Hematological Effects of Intermittent 2-Hour Infusions of Cladribine in Multiple Sclerosis Patients: A Comparison of 2 Dosage Patterns
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology
Link
http://link.springer.com/article/10.1007/BF02982086/fulltext.html
Reference39 articles.
1. Liliemark J.The clinical pharmacokinetics of cladribine.Clin Pharmacokinet. 1997;32:120–131.
2. Carson DA, Wasson DR, Taetle R, Yu A. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes.Blood. 1983;62:737–743.
3. Cheson BD, Sorensen JM, Vena DA, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.J Clin Oncol. 1998;16:3007–3015.
4. Dearden CE, Matutes E, Hilditch BL, Swansbury GJ, Catovsky D. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.Br J Haematol. 1999;106:515–519.
5. Rummel MJ, Chow KU, Jager E, et al. Intermittent 2-hour infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomas.Leuk Lymph. 1999;35:129–138.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential mechanisms of action related to the efficacy and safety of cladribine;Multiple Sclerosis and Related Disorders;2019-05
2. Novel Agents and Emerging Treatment Strategies in Multiple Sclerosis. What Role for Cladribine?;Clinical Medicine Insights: Therapeutics;2011-01
3. The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation;Current Medical Research and Opinion;2007-09-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3